NKMAX Co., Ltd.
Develops NK cell-based therapies, diagnostics, and biological products.
182400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7182400002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 돌마로 172 정자동, 헬스케어혁신파크 1층및6층, 성남시
- Website:
- https://nkmax.com/
- Sector:
- Manufacturing
Description
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-10 00:00 |
[기재정정]주권관련사채권의취득결정
|
Korean | 39.0 KB | ||
| 2023-10-10 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인)(표준요법에 실패한 전이 또는 국소적으로 진행된 고형암 환자를 대상으로 SNK02 정맥 투여의 내약…
|
Korean | 11.8 KB | ||
| 2023-10-06 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 114.6 KB | ||
| 2023-10-06 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 7.8 KB | ||
| 2023-10-04 00:00 |
해외증권시장주권등상장(종속회사의주요경영사항)
|
Korean | 9.6 KB | ||
| 2023-09-15 00:00 |
주권관련사채권의취득결정
|
Korean | 35.6 KB | ||
| 2023-09-13 00:00 |
증권발행결과(자율공시)
|
Korean | 5.6 KB | ||
| 2023-09-12 00:00 |
증권발행결과(자율공시)
|
Korean | 5.6 KB | ||
| 2023-09-11 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 114.6 KB | ||
| 2023-09-11 00:00 |
주요사항보고서(신주인수권부사채권발행결정)
|
Korean | 43.0 KB | ||
| 2023-09-08 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 98.4 KB | ||
| 2023-08-17 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 114.6 KB | ||
| 2023-08-14 00:00 |
반기보고서 (2023.06)
|
Korean | 1.1 MB | ||
| 2023-07-21 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 9.1 KB | ||
| 2023-07-17 00:00 |
전환가액의조정
|
Korean | 11.6 KB |
Automate Your Workflow. Get a real-time feed of all NKMAX Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NKMAX Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NKMAX Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
